SCHEMBL25136802

SCHEMBL25136802

CCCC(C)(C)N1CCc2ccccc2C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.47
MAOB P27338 2/20 0.47
MAPT P10636 3/20 0.41
TAAR1 Q96RJ0 3/20 0.41
LMNA P02545 1/20 0.41
RIPK1 Q13546 2/20 0.41
NOTUM Q6P988 1/20 0.40
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
CARM1 Q86X55 1/20 0.39
PHGDH O43175 1/20 0.39
MGLL Q99685 1/20 0.39
DRD2 P14416 1/20 0.39
DRD1 P21728 1/20 0.39
DRD4 P21917 1/20 0.39
DRD5 P21918 1/20 0.39
DRD3 P35462 1/20 0.39
POLB P06746 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2617033 0.86 MAOA (0.50) MAOAMAOBMAPTTAAR1LMNA
SCHEMBL4666005 0.81 MAOA (0.48) MAOAMAOBMAPTTAAR1LMNA
SCHEMBL19955090 0.79 MAOA (0.46) MAOAMAOBMAPTTAAR1LMNA
SCHEMBL861951 0.78 MAOA (0.57) MAOAMAOBMAPTTAAR1LMNA
SCHEMBL20078475 0.77 MAOA (0.55) MAOAMAOBMAPTTAAR1RIPK1
SCHEMBL19651870 0.77 MAOA (0.45) MAOAMAOBMAPTTAAR1LMNA
SCHEMBL23032152 0.74 MAOA (0.41) MAOAMAOBMAPTTAAR1LMNA
SCHEMBL22867647 0.74 ALDH1A1 (0.40) MAOAMAOBMAPTRIPK1NOTUM
SCHEMBL24511950 0.73 ALDH1A1 (0.44) MAPTLMNANOTUMDRD2DRD4
SCHEMBL20609581 0.72 RIPK1 (0.41) MAOAMAOBMAPTRIPK1NOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230121086-A1 RORgT INHIBITOR, PREPARATION METHOD THEREOF AND USE THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2023-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230121086-A1 RORgT INHIBITOR, PREPARATION METHOD THEREOF AND USE THEREOF RORC, RORB, RORA MAOA 4285/4885MAOB 4173/4885MAPT 1063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.